Drug Pipeline News Drug Pipeline List

Drug Pipeline News Drug Pipeline List


Abbott Gets FDA Approval For Lower-Strength HIV Drug November, 2007





Abbott Laboratories (ABT) received Food and Drug Administration approval for a new lower-strength tablet formulation of its HIV protease inhibitor, Kaletra, for pediatric patients.

The lower-strength Kaletra tablets will be available in the U.S. this month.

Drug Pipeline News archive:






Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.